What is MS Pharma?
MS Pharma is a multinational pharmaceutical company with a strong operational footprint in the MENA region. The company specializes in the development, production, and distribution of a diverse range of generic and specialty medicines. Its extensive product portfolio spans multiple therapeutic areas, including cardiovascular, central nervous system, respiratory, and oncology, boasting over 2000 marketing authorizations. Headquartered in Amman, Jordan, with a corporate office in Switzerland, MS Pharma is strategically positioned to foster rapid business growth and serve as a key partner for pharmaceutical entities aiming to expand within the Middle East and Africa.
How much funding has MS Pharma raised?
MS Pharma has raised a total of $75M across 2 funding rounds:
Debt
$30M
Private Equity
$45M
Debt (2015): $30M with participation from European Bank for Reconstruction and Development
Private Equity (2017): $45M led by International Finance Corporation
Key Investors in MS Pharma
European Bank for Reconstruction and Development
The European Bank for Reconstruction and Development (EBRD) is a multilateral bank committed to the development of market-oriented economies and the promotion of private and entrepreneurial initiatives.
International Finance Corporation
International Finance Corporation operates as a multilateral financial institution dedicated to mobilizing capital and expertise for sustainable development across emerging markets. The organization provides comprehensive financial solutions that combine investment capital, strategic advisory services, and sophisticated asset management capabilities to support private sector growth and infrastructure development in developing economies.
What's next for MS Pharma?
The recent major strategic investment signals a pivotal phase for MS Pharma, likely enabling significant advancements in research and development, market penetration, and potentially new product launches. This capital injection is expected to fuel the company's ambition to become a leading pharmaceutical partner in the MEA region, potentially through strategic acquisitions, enhanced manufacturing capabilities, or expanded distribution networks. MS Pharma's focus on generic and biotech products, coupled with its established presence, positions it for continued success and influence within the global pharmaceutical landscape.
See full MS Pharma company page
